Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-10-12
2010-06-08
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S217050, C540S579000, C540S599000
Reexamination Certificate
active
07732438
ABSTRACT:
Compounds of Formula (I) and Formula (II) (where variables R1, R2, R4, A, B, W, X, Y and Z are as defined herein) useful as antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
REFERENCES:
patent: WO 2004/092166 (2004-10-01), None
Supplementary Search Report for counterpart EPO Appln. No. 05803913.2.
Paone Daniel V.
Potteiger Craig M.
Shaw Anthony W.
Devlin Gerard
Kifle Bruck
Merck Sharp & Dohme Corp.
Yuro Raynard
LandOfFree
CGRP receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with CGRP receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CGRP receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4240961